Dr. Munk is currently a Senior Lecturer in the Chemistry Department at Wayne State University where she is responsible for teaching classes in various areas of chemistry to undergraduate chemistry majors and students in the preparatory programs for health care professions. She also serves as Chair of the Chemistry Department Safety Committee and is responsible for coordinating communications between various University departments to in order to comply with current regulations and help ensure a safe environment for undergraduate teaching and graduate student research laboratories. Prior to joining the faculty at Wayne State University, Dr. Munk worked as a research chemist and as a manager with a diverse set of industrial companies including Warner-Lambert/Pfizer, Allergan Pharmaceuticals, the Clorox Company, Great Lakes Chemical Corporation, the Stepan Company, and Port Systems, LLC (a start-up company in Ann Arbor, MI). During her 25 years in industry, she has been involved in research and development activities from phase I through phase III and the ultimate filing of New Drug Applications. While at the University of California at Irvine, Dr. Munk was involved with the development of UC-ACCESS, an early online system designed to help academic scientists find industrial partners with whom to develop emerging technologies. Her chemical research efforts are summarized in 13 publications and patents. She has also co-edited a laboratory manual for undergraduate general chemistry. Dr. Munk was recently co-author with Susan Miller (University of California, San Francisco), Walter H. Moos (SRI International) and Stephen A Munk (Ash Stevens, Inc) on their book entitled "Managing the Drug Discovery Process - How to make it more efficient and cost-effective". She holds a Ph.D. in Chemistry from Wayne State University, a M.S. in Management from Purdue University and a B.S. in Chemistry from Arizona State University.
Education – Degrees, Licenses, Certifications
- BS Chemistry, Arizona State 1979
- MS Management, Purdue University 1990
- Ph.D Physical Chemistry, Wayne State University 2009
Miller, S. M.; Moos, W. H.; Munk, B.H.; Munk, S.A.; Managing the Drug Discovery Process, How to make it more efficient and cost-effective, Cambridge, MA; Elsevier, 2016
Wentworth, R.; Munk, B. H.; Experiments in General Chemistry, Laboratory Manual, 10th edition, Cengage Learning, 2016.
Thapa, B; Schlegel, H. B.; Munk, B. H.; Burrows, C. J.; Computational Study of the Radical Mediated Mechanism of the Formation of C8, C5 and C4 Guanine:Lysine Adducts in Presence of the Benzophenone Photosensitizer. Chem. Res. Tox. 2016, 29, 1396-1409 (10.1021/acs.chemrestox.6b00057).
Psciuk, B. T.; Lord, R. L.; Munk, B. H.; Schlegel, H. B.; Theoretical Determination of One-Electron Oxidation Potentials for Nucleic Acid Bases. J. Chem. Theory Comput. 2012, 8, 5107−5123 (10.1021/ct300550x).
Ye, Y., Munk, B. H., Muller, J. G., Cogbill, A., Burrows, C. J., Schlegel, H. B. “Mechanistic and Kinetic Aspects of the Formation of Guanidinohydantoin from Spiroiminodihydantoin under Acid Conditions”, Chem. Res. Toxicol., 2009, 22, 526-535 .
Verdolino, V., Cammi, R., Munk, B. H., Schlegel, H. B. “Efforts Toward the Development of a Computational Procedure for Predicting the pKa of DNA Nucleobases and their Oxidation Products”, J. Chem. Phys. B. 2008, 130,5245-5256.
Munk, B.H., Burrows, C. J., Schlegel, H. B. “An Exploration of Mechanisms for the Transformation of 8-oxoguanine to Guanidinohydantoin and Spiroiminodihydantoin by Density Functional Theory”, J. Am. Chem. Soc. 2008, 15, 5245-5256.
CHM 2290 General Chemistry II: Analytical Chemistry Laboratory, 2 credit hours F2017
CHM 2280 General Chemistry II: Analytical Chemistry, 3 credit hours W2016
CHM 2280 General Chemistry II: Analytical Chemistry, 3 credit hours S2016
CHM 2290 General Chemistry II: Analytical Chemistry Laboratory, 2 credit hours S2016
CHM 2290 General Chemistry II: Analytical Chemistry Laboratory, 2 credit hours F2016
CHM 5550 Physical Chemistry Laboratory, 2 credit hours F2016